Skip to main content
Premium Trial:

Request an Annual Quote

BGI to Demo RNA-seq's Ability to Predict Patient Outcomes as Part of FDA-Led SEQC Project

Premium

BGI said last week that it is conducting RNA-seq studies in 500 neuroblastoma samples to show the technique's ability to predict patient outcomes as part of the US Food and Drug Administration's Sequencing Quality Control Project.

SEQC is the third phase of the MicroArray Quality Control project and aims to assess the technical performance of next-generation sequencing platforms for RNA and DNA analyses.

BGI said that it will perform the library construction, sequencing, and bioinformatics analysis for the 500 neuroblastoma samples. The results will be compared to microarray data.

The University Children's Hospital of Cologne is collaborating with BGI on the project. "While we have built predictive models for neuroblastoma patients with microarray data, some of those still need to be improved," Matthias Fischer, a researcher at the university, said in a statement.

Compared to microarrays, RNA-seq data could be utilized to "better understand human transcriptomics and identify functional genetic variants associated with disease and drug risks," he added.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.